General Information of Drug Off-Target (DOT) (ID: OTYKC1AJ)

DOT Name Speedy protein A (SPDYA)
Synonyms Rapid inducer of G2/M progression in oocytes A; RINGO A; hSpy/Ringo A; Speedy-1; Spy1
Gene Name SPDYA
Related Disease
Breast cancer ( )
Breast carcinoma ( )
Advanced cancer ( )
Colorectal carcinoma ( )
Epithelial ovarian cancer ( )
Glioma ( )
Ovarian cancer ( )
Ovarian neoplasm ( )
Plasma cell myeloma ( )
Triple negative breast cancer ( )
Hepatocellular carcinoma ( )
Pneumococcal infection ( )
Amyotrophic lateral sclerosis ( )
Cutaneous mastocytosis ( )
Neoplasm ( )
UniProt ID
SPDYA_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
5UQ1; 5UQ2; 5UQ3; 7E34
Pfam ID
PF11357
Sequence
MRHNQMCCETPPTVTVYVKSGSNRSHQPKKPITLKRPICKDNWQAFEKNTHNNNKSKRPK
GPCLVIQRQDMTAFFKLFDDDLIQDFLWMDCCCKIADKYLLAMTFVYFKRAKFTISEHTR
INFFIALYLANTVEEDEEETKYEIFPWALGKNWRKLFPNFLKLRDQLWDRIDYRAIVSRR
CCEEVMAIAPTHYIWQRERSVHHSGAVRNYNRDEVQLPRGPSATPVDCSLCGKKRRYVRL
GLSSSSSLSSHTAGVTEKHSQDSYNSLSMDIIGDPSQAYTGSEVVNDHQSNKGKKTNFLK
KDKSMEWFTGSEE
Function
Regulates the G1/S phase transition of the cell cycle by binding and activating CDK1 and CDK2. Contributes to CDK2 activation without promoting CDK2 phosphorylation, by inducing a conformation change of the CDK2 T-loop that obstructs the substrate-binding cleft prior to kinase activation. Mediates cell survival during the DNA damage process through activation of CDK2.
Tissue Specificity
Highly expressed in testis. Expressed at a low level in wide range of tissues including bone marrow, brain, heart, kidney, colon, liver, placenta, spleen, skeletal muscle, salivary gland, thyroid gland, thymus, trachea and uterus. Expressed at a slightly higher level in adrenal gland, cerebellum, small intestine, lung, prostate and trachea. Expression is cell cycle-dependent, being restricted to cells in G1/S phase.
KEGG Pathway
Oocyte meiosis (hsa04114 )
Progesterone-mediated oocyte maturation (hsa04914 )

Molecular Interaction Atlas (MIA) of This DOT

15 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Breast cancer DIS7DPX1 Definitive Altered Expression [1]
Breast carcinoma DIS2UE88 Definitive Altered Expression [1]
Advanced cancer DISAT1Z9 Strong Biomarker [2]
Colorectal carcinoma DIS5PYL0 Strong Altered Expression [3]
Epithelial ovarian cancer DIS56MH2 Strong Altered Expression [4]
Glioma DIS5RPEH Strong Biomarker [5]
Ovarian cancer DISZJHAP Strong Altered Expression [4]
Ovarian neoplasm DISEAFTY Strong Altered Expression [4]
Plasma cell myeloma DIS0DFZ0 Strong Biomarker [6]
Triple negative breast cancer DISAMG6N Strong Genetic Variation [7]
Hepatocellular carcinoma DIS0J828 moderate Altered Expression [8]
Pneumococcal infection DIS6SXQD moderate Biomarker [9]
Amyotrophic lateral sclerosis DISF7HVM Disputed Biomarker [10]
Cutaneous mastocytosis DISLBZEF Limited Biomarker [11]
Neoplasm DISZKGEW Limited Biomarker [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Speedy protein A (SPDYA). [12]
Malathion DMXZ84M Approved Malathion increases the expression of Speedy protein A (SPDYA). [13]
Dihydrotestosterone DM3S8XC Phase 4 Dihydrotestosterone increases the expression of Speedy protein A (SPDYA). [14]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Speedy protein A (SPDYA). [15]
------------------------------------------------------------------------------------

References

1 Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.J Pineal Res. 2019 Sep;67(2):e12586. doi: 10.1111/jpi.12586. Epub 2019 Jun 9.
2 Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.EMBO J. 2017 Aug 1;36(15):2251-2262. doi: 10.15252/embj.201796905. Epub 2017 Jun 30.
3 High Spy1 expression predicts poor prognosis in colorectal cancer.Cancer Manag Res. 2018 Aug 16;10:2757-2765. doi: 10.2147/CMAR.S169329. eCollection 2018.
4 Spy1 participates in the proliferation and apoptosis of epithelial ovarian cancer.J Mol Histol. 2016 Feb;47(1):47-57. doi: 10.1007/s10735-015-9646-z. Epub 2015 Dec 7.
5 The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma.Cancer Cell. 2014 Jan 13;25(1):64-76. doi: 10.1016/j.ccr.2013.12.006.
6 Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells.Int J Hematol. 2013 Oct;98(4):446-55. doi: 10.1007/s12185-013-1435-4. Epub 2013 Sep 14.
7 Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.Breast Cancer Res. 2018 Sep 3;20(1):101. doi: 10.1186/s13058-018-1039-2.
8 Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation.Carcinogenesis. 2020 Jul 10;41(6):850-862. doi: 10.1093/carcin/bgz164.
9 Protective Regulatory T Cell Immune Response Induced by Intranasal Immunization With the Live-Attenuated Pneumococcal Vaccine SPY1 via the Transforming Growth Factor-1-Smad2/3 Pathway.Front Immunol. 2018 Aug 2;9:1754. doi: 10.3389/fimmu.2018.01754. eCollection 2018.
10 Spy1, a unique cell cycle regulator, alters viability in ALS motor neurons and cell lines in response to mutant SOD1-induced DNA damage.DNA Repair (Amst). 2019 Feb;74:51-62. doi: 10.1016/j.dnarep.2018.12.005. Epub 2018 Dec 21.
11 Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).Breast Cancer Res Treat. 2012 Apr;132(3):1049-62. doi: 10.1007/s10549-011-1895-2. Epub 2011 Dec 25.
12 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
13 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
14 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
15 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.